Clinical Trials Browser

Phase EARLY_PHASE1 × Active not recruiting × fludarabine × Clear all

NCT05495464 2026-05-20

A Pilot "Window-3" Study of Acalabrutinib Plus Rituximab Followed by Brexucabtagene Autoleucel Therapy in Patients With Previously Untreated High-risk Mantle Cell Lymphoma

Phase EARLY_PHASE1 Active not recruiting

Lymphoma, Lymphoma, Mantle-Cell